E-LIB Suche - Ergebnisse für: De Vries, EGE

1

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions ..:

Cherny, N.I. ; Sullivan, R. ; Dafni, U....
ESMO Open. 1 (2016) 5 - p. e000100 , 2016

Link: https://doi.org/10.1136/..

2

Development of a radioiodinated apoptosis–inducing ligand, ..:

Duiker, EW ; Dijkers, ECF ; Lambers Heerspink, H...
British Journal of Pharmacology. 165 (2012) 7 - p. 2203-2212 , 2012

Link: https://doi.org/10.1111/..

3

Targeting TRAIL death receptors:

Oldenhuis, CNAM ; Stegehuis, JH ; Walenkamp, AME..
Current Opinion in Pharmacology. 8 (2008) 4 - p. 433-439 , 2008

Link: https://doi.org/10.1016/..

4

Efficacy of high-dose alkylating chemotherapy in the adjuva..:

for the Netherlands Working Party on Autologous Transplantation in Solid Tumors ; Rodenhuis, S ; Bontenbal, M...
Breast Cancer Research. 7 (2005) S1 - p. , 2005

Link: https://doi.org/10.1186/..

5

Effects of impaired renal function on the pharmacokinetics ..:

de Jonge, Maja JA ; Glimelius, B ; Verweij, Jaap...
Anti-Cancer Drugs. 13 (2002) 6 - p. 645-653 , 2002

Link: https://doi.org/10.1097/..

6

High-dose chemotherapy in breast cancer: Dutch randomized s..:

Rodenhuis, S ; van Tinteren, H ; de Vries, EGE
Breast Cancer Research. 3 (2001) S1 - p. , 2001

Link: https://doi.org/10.1186/..

7

Fostriecin: a review of the preclinical data:

de Jong, R S ; de Vries, EGE ; Mulder, N H
Anti-Cancer Drugs. 8 (1997) 5 - p. 413-418 , 1997

Link: https://doi.org/10.1097/..

8

PP65. Economic evaluation of high dose chemotherapy for bre..:

van Enckevort, PJ ; TenVergert, EM ; de Vries, EGE.
European Journal of Cancer. 33 (1997) - p. S38 , 1997

Link: https://doi.org/10.1016/..

9

Chemotherapy (CT) dose intensification in ovarian cancer (O..:

Gameren, MM ; Willemse, PHB ; Mull, R..
European Journal of Cancer. 29 (1993) - p. S54 , 1993

Link: https://doi.org/10.1016/..

10

Interleukin-6 as antitumour agent in renal cell carcinoma:

Stouthard, JML ; Poorter, RL ; Bakker, PJM...
European Journal of Cancer. 29 (1993) - p. S234 , 1993

Link: https://doi.org/10.1016/..

11

Amiodarone as modulator of drug-resistance of doxorubicin, ..:

Van der Graaf, WTA ; de Vries, EGE ; Mulder, NH
European Journal of Cancer. 29 (1993) - p. S113 , 1993

Link: https://doi.org/10.1016/..

12

Mitoxantrone: Bluebeard for malignancies:

van der Graaf, WTA ; de Vries, EGE
Anti-Cancer Drugs. 1 (1990) 2 - p. 109-126 , 1990

Link: https://doi.org/10.1097/..

13

ESMO-Magnitude of Clinical Benefit Scale for haematological..:

Kiesewetter, B ; Dafni, U ; de Vries, EGE...
https://www.repository.cam.ac.uk/handle/1810/353404. , 2023

Link: https://www.repository.c..

14

The ESMO Call to Action on COVID-19 vaccinations and patien..:

Garassino, M.C ; Vyas, M ; de Vries, EGE...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.annonc.2021.01.068. , 2021

Link: https://serval.unil.ch/n..

15

CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advance..:

Naing, A ; Thistlethwaite, F ; De Vries, EGE...
https://discovery.ucl.ac.uk/id/eprint/10133504/1/e002447.full.pdf. , 2021

Link: https://discovery.ucl.ac..